Youtube
NECLIFE

Nectar Lifesciences Ltd.

₹26.00

Score

35

Technically Neutral

Nectar Lifesciences Price Change Analysis

Nectar Lifesciences Key Statistics
  • P/E Ratio

    -11.7

  • PEG Ratio

    1.9

  • Market Cap Cr

    583.1

  • Price to Book Ratio

    47.5

  • EPS

    -2.1

  • Dividend

    0 ()

  • Relative Strength Index

    40.33

  • Money Flow Index

    20.42

  • MACD Signal

    -0.76

  • Average True Range

    1.65

Investment Ratings

  • Master Rating:

EPS Strength

Price Strength

Buyer Demand

Group Rank

Result Highlights

Nectar Lifesciences Synopsis

NSE-Medical-Generic Drugs

Nectar Lifesciences is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1541.82 Cr. and Equity Capital is Rs. 22.43 Cr. for the Year ended 31/03/2021. Nectar Lifesciences Ltd. is a Public Limited Listed company incorporated on 27/06/1995 and has its registered office in the State of Punjab, India. Company’s Corporate Identification Number(CIN) is L24232PB1995PLC016664 and registration number is 016664.
  • Market Cap

    580.84

  • Sales

    1,540.78

  • Shares in Float

    12.56

  • No of Funds

    5

  • Yield

    0.22

  • Book Value

    0.53

  • U/D Vol Ratio

    1.1

  • LTDebt/Equity

    12

  • Alpha

    -0.01

  • Beta

    1.35

Nectar Lifesciences Ownership
Nectar Lifesciences Management

Nectar Lifesciences Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Eps And Sales Estimates

Nectar Lifesciences Financials

Nectar Lifesciences Technicals

EMA & SMA

CURRENT PRICE

EMA

Nectar Lifesciences Resistance and Support

Nectar Lifesciences Delivery and Volume

Nectar Lifesciences Price Change Analysis

Corporate Action

MF Shareholding

Similar Stocks

Videos

About Company

News

FAQs

Nectar Lifesciences share price is

Open Demat Account